Journal ArticleOPEN ACCESS

Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma

Journal of Gastroenterology and Hepatology (Australia) (2012) 27(SUPPL.3) 88-94
DOI: 10.1111/j.1440-1746.2012.07078.x
11Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and Aims: The most effective treatment would be neoadjuvant chemoradiotherapy (NACRT) plus surgery with three-field lymphadenectomy, if tolerability and complications are acceptable. The aim of this prospective study was to evaluate the tolerability of NACRT+ systematic three-field lymphadenectomy. Methods: A total of 127 cases of advanced esophageal carcinoma were objected, among which 32 had NACRT, being the cases suspected to cT3-T4 or,

Author supplied keywords

Cite

CITATION STYLE

APA

Kuroda, J., Yoshida, M., Kitajima, M., Yanagisawa, A., Matsubara, T., Yamaguchi, T., … Yamashita, Y. (2012). Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma. Journal of Gastroenterology and Hepatology (Australia), 27(SUPPL.3), 88–94. https://doi.org/10.1111/j.1440-1746.2012.07078.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free